(Q40147464)

17 September 2017

title

Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas (English)

1 reference

17 September 2017

Zisman-Rozen S

1

1 reference

17 September 2017

Fink D

2

1 reference

17 September 2017

Ben-Izhak O

3

1 reference

17 September 2017

Fuchs Y

4

1 reference

17 September 2017

Brodski A

5

1 reference

17 September 2017

Kraus MH

6

1 reference

17 September 2017

Bejar J

7

1 reference

17 September 2017

Ron D

8

1 reference

17 September 2017

language of work or name

English

0 references

publication date

9 April 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

26

1 reference

17 September 2017

issue

41

1 reference

17 September 2017

page(s)

6093-6098

1 reference

Origins and molecular pathology of ovarian cancer

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

Oncogenic kinase signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

1 reference

7 January 2021

Fibroblast growth factor signaling in tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

Sef is synexpressed with FGFs during chick embryogenesis and its expression is differentially regulated by FGFs in the developing limb

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

The ErbB receptors and their ligands in cancer: an overview.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

Alternative splicing generates an isoform of the human Sef gene with altered subcellular localization and specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

Sef is a spatial regulator for Ras/MAP kinase signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

Identification of Sef, a novel modulator of FGF signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

The human sef-a isoform utilizes different mechanisms to regulate receptor tyrosine kinase signaling pathways and subsequent cell fate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210424

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210424

1 reference

Dimensions Publication ID

17 September 2017

1039741337

0 references

1 reference